Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P10114
UPID:
RAP2A_HUMAN
Alternative names:
RbBP-30
Alternative UPACC:
P10114; B2RCJ1; Q5JSC1; Q5JSC2
Background:
Ras-related protein Rap-2a, also known as RbBP-30, is a pivotal small GTP-binding protein. It oscillates between GDP-bound inactive and GTP-bound active states, influencing various effectors like MAP4K4, MINK1, and TNIK. This protein is integral to a signaling complex with NEDD4, RAP2A, and TNIK, crucial for neuronal dendrite extension and arborization during development. It plays a significant role in signaling cascades, affecting cytoskeletal rearrangements, cell migration, adhesion, and spreading.
Therapeutic significance:
Understanding the role of Ras-related protein Rap-2a could open doors to potential therapeutic strategies.